|
1. Wang C, Luo J, Amer S, Guo Y, Hu Y, Lu Y, et al. Multivalent DNA vaccine induces protective immune responses and enhanced resistance against Cryptosporidium parvum infection. Vaccine 2011; 29(2): 323–8. 2. Petry F, Jakobi V, Tessema TS. Host immune response to Cryptosporidium parvum infection. Exp Parasitol 2010; 126(3): 304-9. 3. Singh I, Theodos C, Tzipori S. Recombinant proteins of Cryptosporidium parvum induce proliferation of mesenteric lymph node cells in infected mice. Infect Immun 2005; 73(8): 5245-8. 4. Bouzid M, Hunter PR, Chalmers RM, Tyler KM. Cryptosporidium Pathogenicity and Virulence. Clin Microbiol Rev 2013; 26(1): 115-34. 5. Boulter-Bitzer JI1, Lee H, Trevors JT. Molecular targets for detection and immunotherapy in Cryptosporidium parvum. Biotechnol Adv 2007; 25(1): 13-44. 6. Ehigiator HN, Romagnoli P, Priest JW, Secor WE, Mead JR. Induction of murine immune responses by DNA encoding a 23-kDa antigen of Cryptosporidium parvum. Parasitol Res 2007; 101(4): 943-50. 7. Shayan P, Ebrahimzadeh E, Mokhber-Dezfouli MR, Rahbari S. Recombinant Cryptosporidium parvum p23 as a target for the detection of Cryptosporidium-specific antibody in calf sera. Parasitol Res 2008; 103(5): 1207-11. 8. Ebrahimzadeh M, Shayan P, Mokhber Dezfouli MR, Rahbari S. Recombinant Cryptosporidium parvum p23 as a Candidate Vaccine for Cryptosporidiosis. Iran J Parasitol 2009; 4(1): 1-7. 9. Borad A, Ward H. Human immune responses in cryptosporidiosis. Future Microbiol 2010; 5(3): 507-19. 10. Cevallos AM, Zhang X, Waldor MK, Jaison S, Zhou X, Tzipori S, et al. Molecular cloning and expression of a gene encoding Cryptosporidium parvum glycoproteins gp40 and gp15. Infect Immun 2000; 68(7): 4108–16. 11. O’Connor R, Wanyiri J, Cevallos A, Priest J, Ward HD. Cryptosporidium parvum glycoprotein gp40 localizes to the sporozoite surface by association with gp15. Mol Biochem Parasitol 2007; 156(1): 80–3. 12. Wanyiri JW, O’Connor R, Allison G, Kim K, Kane A, Qiu J, et al. Proteolytic Processing of the Cryptosporidium Glycoprotein gp40/15 by Human Furin and by a Parasite-Derived Furin-Like Protease Activit. Infect Immun 2007; 75(1): 184–92. 13. O’Connor RM, Kim K, Khan F, Ward HD. Expression of Cpgp40/15 in Toxoplasma gondii: a Surrogate System for the Study of Cryptosporidium Glycoprotein Antigens. Infect Immun 2003; 71(10): 6027–34. 14. O’Connor RM, Wanyiri J, Wojczyk B, Kim K, Ward H. Stable expression of Cryptosporidium parvum glycoprotein gp40/15 in Toxoplasma gondii. Mol Biochem Parasitol 2007; 152(2): 149–58. 15. Tilley M, Upton SJ, Fayer R, Barta JR, Chrisp CE, Freed PS, et al. Identification of a 15-kilodalton surface glycoprotein on sporozoites of Cryptosporidium parvum. Infect Immun 1991; 59(3): 1002–7. 16. Leav BA, Mackay MR, Anyanwu A, O’ Connor RM, Cevallos AM, Kindra G, et al. Analysis of Sequence Diversity at the Highly Polymorphic Cpgp40/15 Locus among Cryptosporidium Isolates from Human Immuno deficiency Virus-Infected Children in South Africa. Infect Immun 2002; 70(7): 3881–90. 17. Sambrook J, Russel DW. Molecular cloning: A laboratory manual, third edition. Plainview: Cold Spring Harbor Laboratory Press. Cold Spring Harbor New York; 2001. 18. Lan DT, Lan TT, Viet LQ, Quyet PV, Quang HT, Loc NH, et al. Cloning and expression of gene encoding P23 protein from Cryptosporidium parvum. J BioSci Biotech 2014; 3(3): 189-93. 19. Ahmadi AH, Honari H, Minaei ME. Cloning, Fusion, and Expression of Domain a-1 Protective Antigen (PA20) of Bacillus anthracis and N-Terminal ipaD Gene of Shigella in E. coli. Qom Univ Med Sci J 2015; 9(4): 20-9. [in Persian] 20. Bradford MM. Arapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1979; 72: 248-54. 21. Rossle NF, Latif B. Cryptosporidiosis as threatening health problem: A review. Asian Pac J Trop Biomed 2013; 3(11): 916–24. 22. Manque PA, Tenjo F, Woehlbier U, Lara AM, Serrano MG, Xu P, et al. Identification and immunological characterization of three potential vaccinogens against Cryptosporidium species. Clin Vaccine Immunol 2011; 18(11): 1796-802. 23. Allison GM, Rogers KA, Borad A, Ahmed S, Karim MM, Kane AV, et al. Antibody responses to the immunodominant Cryptosporidium gp15 antigen and gp15 polymorphisms in a case-control study of cryptosporidiosis in children in Bangladesh. Am J Trop Med Hyg 2011; 85(1): 97-104. 24. Liu K, Zai D, Zhang D, Wei Q, Han G, Gao H, et al. Divalent Cp15-23 vaccine enhances immune responses and protection against Cryptosporidium parvum infection. Parasite Immunol 2010; 32(5): 335-44. 25. Strong W B, Gut J, Nelson Richar G. Cloning and Sequence Analysis of a Highly Polymorphic Cryptosporidium parvum Gene Encoding a 60-Kilodalton Glycoprotein and Characterization of Its 15- and 45-Kilodalton Zoite Surface Antigen Products. Infect Immun 2000; 68(7): 4117–34.
|
.png){kind=logo}
